Anbio Biotechnology (NASDAQ:NNNN – Get Free Report) gapped up prior to trading on Monday . The stock had previously closed at $8.74, but opened at $10.17. Anbio Biotechnology shares last traded at $8.8980, with a volume of 371,901 shares.
Analyst Upgrades and Downgrades
Separately, Weiss Ratings lowered shares of Anbio Biotechnology from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, July 29th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat, Anbio Biotechnology has a consensus rating of “Sell”.
Check Out Our Latest Research Report on NNNN
Anbio Biotechnology Stock Performance
Anbio Biotechnology Company Profile
Anbio Biotechnology is dedicated to the advancement of medical technology and the provision of in vitro diagnostics (IVD) products. Our unwavering commitment lies in transforming the diagnostics landscape on a global scale, fostering a paradigm shift towards personalized and decentralized diagnostic solutions. By doing so, we aim to significantly enhance patient prognosis and contribute to the betterment of healthcare worldwide. At Anbio Biotechnology, our extensive portfolio comprises an array of IVD products designed to cater to diverse diagnostic needs.
Further Reading
- Five stocks we like better than Anbio Biotechnology
- Looking Beyond CrowdStrike? 3 AI Security Stocks Stand Out
- 5 Recession-Proof Stocks Hiding in Cardboard Boxes
- These 5 Dividend Stocks Show Why Income Investing Still Matters
- The Quantum Race Is Heating Up—And 2 Small Players Stand Out
Receive News & Ratings for Anbio Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anbio Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
